Newron Pharmaceuticals SpA Financials
| NWPHFDelisted Stock | USD 2.10 0.00 0.00% |
With this module, you can analyze Newron financials for your investing period. You should be able to track the changes in Newron Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Newron |
Understanding current and past Newron Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Newron Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Newron Pharmaceuticals' assets may result in an increase in income on the income statement.
The data published in Newron Pharmaceuticals' official financial statements usually reflect Newron Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Newron Pharmaceuticals. For example, before you start analyzing numbers published by Newron accountants, it's critical to develop an understanding of what Newron Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Newron Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Newron Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Newron Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Newron Pharmaceuticals SpA. Please utilize our Beneish M Score to check the likelihood of Newron Pharmaceuticals' management manipulating its earnings.
Newron Pharmaceuticals Stock Summary
Newron Pharmaceuticals competes with Ambev SA, United Parks, JD Sports, Vita Coco, and BRP. Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy. Newron Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 23 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCGREY Exchange |
| Business Address | Via Antonio Meucci |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | NYSE Composite |
| Website | www.newron.com |
| Phone | 39 02 610 3461 |
| Currency | USD - US Dollar |
You should never invest in Newron Pharmaceuticals without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Newron OTC Stock, because this is throwing your money away. Analyzing the key information contained in Newron Pharmaceuticals' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Newron Pharmaceuticals Key Financial Ratios
Generally speaking, Newron Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Newron Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Newron Pharmaceuticals over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Newron Pharmaceuticals reports annually and quarterly.Newron Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Newron Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Newron Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Newron Pharmaceuticals competition to find correlations between indicators driving Newron Pharmaceuticals's intrinsic value. More Info.Newron Pharmaceuticals SpA is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Newron Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Newron Pharmaceuticals' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Newron Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Newron Pharmaceuticals Market Pulse
| Quote | 2.10 |
| Change(%) | 0.00 |
| Change | 0.00 |
| Open | 2.1 |
| Low | 2.1 |
| High | 2.1 |
| Volume | 0 |
| Exchange | OTCGREY |
About Newron Pharmaceuticals Financials
What exactly are Newron Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Newron Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Newron Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Newron Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Newron Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Newron Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Newron Pharmaceuticals Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Newron Pharmaceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Newron has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Newron Pharmaceuticals' financials are consistent with your investment objective using the following steps:- Review Newron Pharmaceuticals' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Newron Pharmaceuticals' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Newron Pharmaceuticals' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Newron Pharmaceuticals' stock is overvalued or undervalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Newron Pharmaceuticals information on this page should be used as a complementary analysis to other Newron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Newron OTC Stock
If you are still planning to invest in Newron Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Newron Pharmaceuticals' history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |